Six were clinical studies, including pilot studies, secondary analyses, and RCTs, and the remaining were preclinical studies, mainly involving rodents
Results of the first phase 3 trial comparing orforglipron with oral semaglutide found that patients with diabetes lost on average 6-8% of their body weight with orforglipron, compared with 4-5% on semaglutide
No, The FDA has warned about unapproved GLP-1 products (including semaglutide and tirzepatide) sold online and mislabeled for research purposes or not for human consumption, with unknown quality and potential harm
Uh since the average age of menopause, we were kind of talking about is around 50, like 51, 52 years
Age- and trauma-dependent modifications of neuromuscular junction and skeletal muscle structure in the rat